Ankylosing spondylitis trials in Netherlands

4 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)

  Where

  Amsterdam, Leiden

  Age

  18 years to 65 years

  People

  140 worldwide

  Run by

  Grey Wolf Therapeutics

  See details and how to joinNCT07047703
• Phase 1Taking people
  EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)

  Where

  Amsterdam

  Age

  18 years and over

  People

  86 worldwide

  Run by

  Grey Wolf Therapeutics Limited

  See details and how to join2025-521315-39-00
• Phase 4Not yet taking people in Netherlands
  Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis

  Where

  Nijmegen

  Age

  18 years and over

  People

  200 worldwide

  Run by

  CARE ARTHRITIS LTD.

  See details and how to joinNCT07018206 · EU 2025-522118-21-00
• Phase 4Taking people
  REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

  Where

  Amsterdam, Enschede, Harderwijk, Maastricht, Nijmegen, Rotterdam, Tilburg, Ubbergen, Uden, Zwolle

  Age

  16 years and over

  People

  200

  Run by

  Sint Maartenskliniek

  See details and how to joinNCT07160231 · EU 2025-520757-36-00